This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
AB InBev (BUD) on Track With Its Growth Efforts: Apt to Hold?
by Zacks Equity Research
Despite cost headwinds, AB InBev's (BUD) rapid expansion of its digital platform, solid demand and continued premiumization bode well.
Molson Coors (TAP) Extends ZOA Energy Deal to Expand Beyond Beer
by Zacks Equity Research
Molson Coors (TAP) increases its investment in ZOA Energy to strengthen its beyond beer portfolio.
Can Strategic Growth Efforts Aid Clorox (CLX) Amid High Costs?
by Zacks Equity Research
Despite inflation concerns, Clorox (CLX) looks well-poised to drive growth on solid demand, pricing actions, cost-saving efforts and other growth strategies.
Nu Skin (NUS) Appears Dull on High Cost & Currency Headwinds
by Zacks Equity Research
Nu Skin's (NUS) margins have been contracting year over year for a while now. The company is also battling unfavorable currency headwinds.
Nomad Foods (NOMD) Reaffirms Q3 & Full-Year 2023 Guidance
by Zacks Equity Research
Nomad Foods (NOMD) continues to expect revenues in the range of EUR750-EUR755 million for the third quarter of 2023.
B&G Foods (BGS) Gains on Pricing Actions & Prudent Buyouts
by Zacks Equity Research
B&G Foods' (BGS) pricing actions have been catching up with higher costs. The company has a successful track record of acquisition-led growth.
Can Strategic Growth Endeavors Aid Newell (NWL) Amid Inflation?
by Zacks Equity Research
Despite inflationary pressures, Newell (NWL) looks promising on the back of cost-cutting initiatives and a solid online show.
Factors That Make Helen of Troy (HELE) an Attractive Bet Now
by Zacks Equity Research
Helen of Troy (HELE) benefits from its focus on a solid Leadership Brand portfolio. The company's global restructuring plan, Project Pegasus, is worth mentioning.
Strategic Pricing Actions Aid Lamb Weston (LW), High Costs Ail
by Zacks Equity Research
Lamb Weston (LW) benefits from robust pricing actions to counter input and manufacturing cost inflation.
Hormel Foods (HRL) Stock Dips on Q3 Earnings & Sales Miss
by Zacks Equity Research
Hormel Foods' (HRL) third-quarter fiscal 2023 results reflect weakness in the Retail and International segments. Continued momentum in the Foodservice unit acts as an upside.
Church & Dwight (CHD) Up More Than 15% YTD: Will It Stay?
by Zacks Equity Research
Constant brand investments, product innovation, effective pricing actions and successful execution are contributing to Church & Dwight's (CHD) growth.
Strength in Brand Portfolio Aids Kellogg (K), Rising Costs Ail
by Zacks Equity Research
Kellogg (K) is focused on investing in brand-building efforts. However, adverse impacts of high input cost inflation and shortages are a concern.
Nu Skin (NUS) Down More Than 30% in 3 Months: Here's Why
by Zacks Equity Research
Nu Skin (NUS) is battling continued macroeconomic hurdles and related price increases, affecting specific key markets, leading to a slowdown in consumer spending and customer acquisition.
Accelerate Strategy Aids General Mills (GIS), High Costs Hurt
by Zacks Equity Research
General Mills (GIS) is focused on its Accelerate strategy, which helps it make choices of how to win and where to play to boost profitability. However, cost inflation is a headwind.
Helen of Troy (HELE) Up More Than 20% in 3 Months: Here's Why
by Zacks Equity Research
Helen of Troy (HELE) is focused on developing the global restructuring plan, Project Pegasus. The company is benefiting from strength in its Leadership Brands.
Capacity Expansions Aid Lamb Weston (LW), High Costs Ail
by Zacks Equity Research
Lamb Weston (LW) is focused on strategic growth efforts like expanding capacity. However, cost inflation for key inputs like raw potatoes, energy and labor is a downside.
COTY's Q4 Earnings Underperform Estimates, Sales Increase
by Zacks Equity Research
COTY's fourth-quarter fiscal 2023 results reflect improved earnings and sales on gains from the Prestige & Consumer Beauty business.
Church & Dwight (CHD) Poised on Prudent Buyouts & Innovations
by Zacks Equity Research
Church & Dwight (CHD) has a long history of acquisitions, which are yielding. The company boasts a portfolio of solid brands.
Campbell Soup (CPB) Benefits From Saving Plans Amid High Costs
by Zacks Equity Research
Campbell Soup (CPB) is on track with efforts to counter inflation, such as supply-chain productivity enhancements and margin-improvement efforts.
Helen of Troy (HELE) Poised on Leadership Brands, Strategies
by Zacks Equity Research
Helen of Troy (HELE) is investing in its Leadership Brands that are yielding well. The company is focused on developing a global restructuring plan, Project Pegasus.
Lamb Weston (LW) Gains on Pricing Action Amid Cost Inflation
by Zacks Equity Research
Lamb Weston (LW) benefits from robust price/mix. Also, the company is focused on undertaking strategic growth efforts like expanding capacity.
Utz Brands (UTZ) Matches Q2 Earnings Estimates
by Zacks Equity Research
Utz Brands (UTZ) delivered earnings and revenue surprises of 0% and 0.84%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Inter Parfums (IPAR) Ups '23 EPS Guidance on Q2 Earnings Beat
by Zacks Equity Research
Inter Parfums' (IPAR) second-quarter 2023 results reflect higher earnings and sales on growth across Europe and U.S.-based operations. Management raises the 2023 earnings view.
Nomad Foods (NOMD) Tops Q2 Earnings Estimates
by Zacks Equity Research
Nomad Foods (NOMD) delivered earnings and revenue surprises of 4.76% and 0.55%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Medifast's (MED) Q2 Earnings Top Estimates, Sales Decline Y/Y
by Zacks Equity Research
Medifast's (MED) second-quarter 2023 results reflect lower sales and earnings on reduced Coach productivity and cost inflation.